icon
icon
icon
icon
Upgrade
icon

Jan. 08 Pre-market Movers Board: Boeing plunges 8% premarket after an explosion occurred on Boeing 737 MAX 9 last Friday

AInvestMonday, Jan 8, 2024 4:43 am ET
1min read

Seize the market opportunities with us at 8:45 every morning, and don't forget to check our "Lunchtime Movers Board" at 12:00.

Premarket Gainers: Harpoon, Vincerx, Heron, Annexon, Molecular

HARP:

HarpoonTherapeutics rockets 102% premarket after reported Merck in talks to buy the Co. for $700M.

VINC:

VincerxPharma soars 59% premarket after announcing compelling clinical efficacy of Enitociclib in combination with Venetoclax and prednisone in lymphoma.

HRTX:

HeronTherapeutics surges 12% premarket after announcing partnership with Crosslink life sciences to expand promotional effort for ZYNRELEF.

ANNX:

Annexon climbs 10% premarket after outlines priorities with late-stage clinical milestones across upstream complement portfolio for autoimmune, ophthalmic and neurodegenerative diseases.

MOLN:

Molecular spikes 5% as the Co. to provide updates at 42nd annual JPM Healthcare conference.

Premarket Losers: LumiraDx, Spirit, Boeing, Alaska Air,  XPeng

LMDX: LumiraDx plunges 29% premarket after announcing its securities will be suspended from trading on Nasdaq.

SPR:

Spirit Aerosystems drops 15% premarket under the effect of Boeing 737 Max explosion.

BA:

Boeing plunges 8% premarket after The FAA required all Boeing 737 MAX 9 aircraft operated within US to be temporarily grounded and undergo safety inspections.

ALK:

Alaska Air sinks 5% premarket after an explosion occurred on one of the company's Boeing 737 MAX 9 aircraft last Friday.

XPEV: 

XPeng sinks 5% premarket after JPM sold HK$334M of the Co.'s HK-listed shares.

$HARP(HARP)$VINC(VINC)$HRTX(HRTX)$ANNX(ANNX)$MOLN(MOLN)$LMDX(LMDX)$SPR(SPR)$BA(BA)$ALK(ALK)$XPEV(XPEV)

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.